How HR Teams Are Restructuring GLP-1 Benefits
With employer healthcare costs projected to rise by 8% to 9% in 2027, many organizations are reevaluating high-cost benefits such as GLP-1 coverage. Demand for these medications remains strong, but because treatment may be long term, offering broad coverage can put significant pressure on pharmacy budgets. However, eliminating coverage can limit access to effective treatment…
Read More



